Outcomes of infants and children with bronchopulmonary dysplasia-associated pulmonary hypertension who required home ventilation.
Journal
Pediatric research
ISSN: 1530-0447
Titre abrégé: Pediatr Res
Pays: United States
ID NLM: 0100714
Informations de publication
Date de publication:
24 Aug 2024
24 Aug 2024
Historique:
received:
09
05
2024
accepted:
05
08
2024
medline:
26
8
2024
pubmed:
26
8
2024
entrez:
24
8
2024
Statut:
aheadofprint
Résumé
To characterize a cohort of ventilator-dependent infants and children with bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH) and to describe their cardiorespiratory outcomes. Subjects with BPD on chronic home ventilation were recruited from outpatient clinics. PH was defined by its presence on ≥1 cardiac catheterization or echocardiogram on or after 36 weeks post-menstrual age. Kaplan-Meier analysis was used to compare the timing of key events. Of the 154 subjects, 93 (60.4%) had PH and of those, 52 (55.9%) required PH-specific medications. The ages at tracheostomy, transition to home ventilator, and hospital discharge were older in those with PH. Most subjects were weaned off oxygen and liberated from the ventilator by 5 years of age, which did not occur later in subjects with PH. The mortality rate after initial discharge was 2.6%. The majority of infants with BPD-PH receiving chronic invasive ventilation at home survived after initial discharge. Subjects with BPD-PH improved over time as evidenced by weaning off oxygen and PH medications, ventilator liberation, and tracheostomy decannulation. While the presence of PH was not associated with later ventilator liberation or decannulation, the use of PH medications may be a marker of a more protracted disease trajectory. There is limited data on long-term outcomes of children with bronchopulmonary dysplasia (BPD) who receive chronic invasive ventilation at home, and no data on those with the comorbidity of pulmonary hypertension (PH). Almost all subjects with BPD-PH who were on chronic invasive ventilation at home survived after their initial hospital discharge. Subjects with BPD-PH improved over time as evidenced by weaning off oxygen, PH medications, liberation from the ventilator, and tracheostomy decannulation. The presence of PH did not result in later ventilator liberation or decannulation; however, the use of outpatient PH medications was associated with later ventilation liberation and decannulation.
Sections du résumé
BACKGROUND
BACKGROUND
To characterize a cohort of ventilator-dependent infants and children with bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH) and to describe their cardiorespiratory outcomes.
METHODS
METHODS
Subjects with BPD on chronic home ventilation were recruited from outpatient clinics. PH was defined by its presence on ≥1 cardiac catheterization or echocardiogram on or after 36 weeks post-menstrual age. Kaplan-Meier analysis was used to compare the timing of key events.
RESULTS
RESULTS
Of the 154 subjects, 93 (60.4%) had PH and of those, 52 (55.9%) required PH-specific medications. The ages at tracheostomy, transition to home ventilator, and hospital discharge were older in those with PH. Most subjects were weaned off oxygen and liberated from the ventilator by 5 years of age, which did not occur later in subjects with PH. The mortality rate after initial discharge was 2.6%.
CONCLUSIONS
CONCLUSIONS
The majority of infants with BPD-PH receiving chronic invasive ventilation at home survived after initial discharge. Subjects with BPD-PH improved over time as evidenced by weaning off oxygen and PH medications, ventilator liberation, and tracheostomy decannulation. While the presence of PH was not associated with later ventilator liberation or decannulation, the use of PH medications may be a marker of a more protracted disease trajectory.
IMPACT STATEMENT
UNASSIGNED
There is limited data on long-term outcomes of children with bronchopulmonary dysplasia (BPD) who receive chronic invasive ventilation at home, and no data on those with the comorbidity of pulmonary hypertension (PH). Almost all subjects with BPD-PH who were on chronic invasive ventilation at home survived after their initial hospital discharge. Subjects with BPD-PH improved over time as evidenced by weaning off oxygen, PH medications, liberation from the ventilator, and tracheostomy decannulation. The presence of PH did not result in later ventilator liberation or decannulation; however, the use of outpatient PH medications was associated with later ventilation liberation and decannulation.
Identifiants
pubmed: 39181986
doi: 10.1038/s41390-024-03495-8
pii: 10.1038/s41390-024-03495-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.
Références
Northway, W. H. Jr, Rosan, R. C. & Porter, D. Y. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N. Engl. J. Med. 276, 357–368 (1967).
doi: 10.1056/NEJM196702162760701
pubmed: 5334613
Malloy, K. W. & Austin, E. D. Pulmonary hypertension in the child with bronchopulmonary dysplasia. Pediatr. Pulmonol. 56, 3546–3556 (2021).
doi: 10.1002/ppul.25602
pubmed: 34324276
pmcid: 8530892
Mourani, P. M. & Abman, S. H. Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and beyond. Curr. Opin. Pediatrics 25, 329–337 (2013).
doi: 10.1097/MOP.0b013e328360a3f6
Bhat, R., Salas, A. A., Foster, C., Carlo, W. A. & Ambalavanan, N. Prospective analysis of pulmonary hypertension in extremely low birth weight infants. Pediatrics 129, e682–689, (2012).
doi: 10.1542/peds.2011-1827
pubmed: 22311993
pmcid: 3289526
Mirza, H. et al. Pulmonary hypertension in preterm infants: prevalence and association with bronchopulmonary dysplasia. J. Pediatrics 165, 909–914 e901 (2014).
doi: 10.1016/j.jpeds.2014.07.040
Mourani, P. M. et al. Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. https://doi.org/10.1164/rccm.201409-1594OC (2014).
Arjaans, S. et al. Identification of gaps in the current knowledge on pulmonary hypertension in extremely preterm infants: a systematic review and meta-analysis. Paediatr. Perinat. Epidemiol. 32, 258–267 (2018).
doi: 10.1111/ppe.12444
pubmed: 29341209
Lagatta, J. M. et al. The impact of pulmonary hypertension in preterm infants with severe bronchopulmonary dysplasia through 1 Year. J. Pediatrics 203, 218–224.e213 (2018).
doi: 10.1016/j.jpeds.2018.07.035
Altit, G., Bhombal, S., Hopper, R. K., Tacy, T. A. & Feinstein, J. Death or resolution: the “natural history” of pulmonary hypertension in bronchopulmonary dysplasia. J. Perinatol. 39, 415–425 (2019).
doi: 10.1038/s41372-018-0303-8
pubmed: 30617286
Khemani, E. et al. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics 120, 1260–1269 (2007).
doi: 10.1542/peds.2007-0971
pubmed: 18055675
Arjaans, S. et al. Fate of pulmonary hypertension associated with bronchopulmonary dysplasia beyond 36 weeks postmenstrual age. Arch. Dis. Child. Fetal Neonatal Ed. 106, 45–50 (2021).
doi: 10.1136/archdischild-2019-318531
pubmed: 32571832
Guaman, M. C. et al. Invasive mechanical ventilation at 36 weeks post-menstrual age, adverse outcomes with a comparison of recent definitions of bronchopulmonary dysplasia. J. Perinatol. 41, 1936–1942 (2021).
doi: 10.1038/s41372-021-01102-w
pubmed: 34035454
pmcid: 8342304
Murthy, K. et al. Inter-center variation in death or tracheostomy placement in infants with severe bronchopulmonary dysplasia. J. Perinatol. 37, 723–727 (2017).
doi: 10.1038/jp.2016.277
pubmed: 28181997
Manimtim, W. M. et al. Respiratory outcomes for ventilator-dependent children with bronchopulmonary dysplasia. Pediatrics 151, https://doi.org/10.1542/peds.2022-060651 (2023).
Jobe, A. H. & Bancalari, E. Bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 163, 1723–1729 (2001).
doi: 10.1164/ajrccm.163.7.2011060
pubmed: 11401896
Oken, E., Kleinman, K. P., Rich-Edwards, J. & Gillman, M. W. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatrics 3, 6 (2003).
doi: 10.1186/1471-2431-3-6
pubmed: 12848901
pmcid: 169185
Wu, K. Y. et al. Characterization of disease phenotype in very preterm infants with severe bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 201, 1398–1406 (2020).
doi: 10.1164/rccm.201907-1342OC
pubmed: 31995403
pmcid: 7258644
Abman, S. H. et al. Characterisation of paediatric pulmonary hypertensive vascular disease from the PPHNet Registry. Eur. Respir. J 59, https://doi.org/10.1183/13993003.03337-2020 (2022).
Yung, D. et al. A multidisciplinary approach to severe bronchopulmonary dysplasia is associated with resolution of pulmonary hypertension. Front. Pediatr. 11, 1077422 (2023).
doi: 10.3389/fped.2023.1077422
pubmed: 37063675
pmcid: 10098720
Mirza, H., Mandell, E. W., Kinsella, J. P., McNamara, P. J. & Abman, S. H. Pulmonary vascular phenotypes of prematurity: the path to precision medicine. J. Pediatrics 259, 113444 (2023).
doi: 10.1016/j.jpeds.2023.113444
Arjaans, S. et al. Clinical significance of early pulmonary hypertension in preterm infants. J. Pediatrics 251, 74–81.e73 (2022).
doi: 10.1016/j.jpeds.2022.07.039
Akangire, G. et al. Outcomes of infants with severe bronchopulmonary dysplasia who received tracheostomy and home ventilation. Pediatr. Pulmonol. 58, 753–762 (2023).
doi: 10.1002/ppul.26248
pubmed: 36377273
Cristea, A. I., Carroll, A. E., Davis, S. D., Swigonski, N. L. & Ackerman, V. L. Outcomes of children with severe bronchopulmonary dysplasia who were ventilator dependent at home. Pediatrics 132, e727–734, (2013).
doi: 10.1542/peds.2012-2990
pubmed: 23918888
pmcid: 3876749
House, M., Nathan, A., Bhuiyan, M. A. N. & Ahlfeld, S. K. Morbidity and respiratory outcomes in infants requiring tracheostomy for severe bronchopulmonary dysplasia. Pediatr. Pulmonol. 56, 2589–2596 (2021).
doi: 10.1002/ppul.25455
pubmed: 34002957
Upadhyay, K., Vallarino, D. A. & Talati, A. J. Outcomes of neonates with tracheostomy secondary to bronchopulmonary dysplasia. BMC Pediatrics 20, 414 (2020).
doi: 10.1186/s12887-020-02324-1
pubmed: 32873254
pmcid: 7459155
Hansen, T. P. et al. A multidisciplinary chronic lung disease team in a neonatal intensive care unit is associated with increased survival to discharge of infants with tracheostomy. J. Perinatol. 41, 1963–1971 (2021).
doi: 10.1038/s41372-021-00974-2
pubmed: 33795789
pmcid: 8013205
Akangire, G. & Manimtim, W. Tracheostomy in infants with severe bronchopulmonary dysplasia: a review. Front. Pediatr. 10, 1066367 (2022).
doi: 10.3389/fped.2022.1066367
pubmed: 36714650
Gibbs, K., Jensen, E. A., Alexiou, S., Munson, D. & Zhang, H. Ventilation strategies in severe bronchopulmonary dysplasia. Neoreviews 21, e226–e237 (2020).
doi: 10.1542/neo.21-4-e226
pubmed: 32238485
Kielt, M. J. et al. Classifying multicenter approaches to invasive mechanical ventilation for infants with bronchopulmonary dysplasia using hierarchical clustering analysis. Pediatr. Pulmonol. 58, 2323–2332 (2023).
doi: 10.1002/ppul.26488
pubmed: 37265416
Gentle, S. J. et al. Intermittent hypoxemia and bronchopulmonary dysplasia with pulmonary hypertension in preterm infants. Am. J. Respir. Crit. Care Med. 207, 899–907 (2023).
doi: 10.1164/rccm.202203-0580OC
pubmed: 36449386
Mahgoub, L. et al. Pulmonary vein stenosis of ex-premature infants with pulmonary hypertension and bronchopulmonary dysplasia, epidemiology, and survival from a multicenter cohort. Pediatr. Pulmonol. 52, 1063–1070 (2017).
doi: 10.1002/ppul.23679
pubmed: 28152279
Mourani, P. M., Ivy, D. D., Rosenberg, A. A., Fagan, T. E. & Abman, S. H. Left ventricular diastolic dysfunction in bronchopulmonary dysplasia. J. Pediatrics 152, 291–293 (2008).
doi: 10.1016/j.jpeds.2007.11.006
Goss, K. N. et al. Early pulmonary vascular disease in young adults born preterm. Am. J. Respir. Crit. Care Med. 198, 1549–1558 (2018).
doi: 10.1164/rccm.201710-2016OC
pubmed: 29944842
pmcid: 6298636
Collaco, J. M. et al. Characteristics of infants or children presenting to outpatient bronchopulmonary dysplasia clinics in the United States. Pediatric Pulmonol. https://doi.org/10.1002/ppul.25332 (2021).